Kalorama Issues New HAI Report on Diagnostic Markets and Testing

July 14, 2011

Kalorama Information, prostate a supplier of medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare, has issued a new report, “Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends.”

According to a press release issued today by the company,┬áKalorama predicts the combined world market for testing and treatment products for HAI will reach $10.3 billion in 2015, up from $9 billion in 2010, with higher growth experienced in the testing segment.”

The following market data is provided in the report:

  • Market for HAI Diagnostics
  • Forecast for HAI Diagnostics to 2015
  • HAI Tests on the Market
  • Market for Diagnostics by Infection Type (C. Diff., MRSA, Pneumonia, Other)
  • Molecular HAI Market vs. Conventional HAI Market, Present and in 2015
  • Geographic Breakdown of Testing (U.S., Europe, Asia, ROW)
  • New Hospital Infection Product Testing Products in the Market
  • Company Profiles
  • Treatment Products on the Market, HAI Antibiotic market Size and Forecast
Note: there is a considerable fee for the report, although the abstract summary provides a good overview information of what is contained in the report.


Leave a Comment

Previous post:

Next post: